VCAM1 and breast carcinoma: As for example shown by Carlson et al. for breast carcinoma cells, DTCs occupy perivascular niches through integrin-mediated interactions driven by endothelial-derived von Willebrand factor and vascular cell adhesion molecule 1 (VCAM-1) and thereby receive selective protection against chemotherapies [87].